Skip to main content

Table 6 Baseline characteristics of potentially relapsing patients

From: A systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malaria

Authors, year of publication Patient’s status Age (years) Sex Probable origin of infection Chemoprophylaxis Parasitaemia (parasites/µl)
Bottieau [28], 2005 T 17 M Ghana Mefloquine
T 22 M Nigeria Mefloquine
T 14 M Uganda None
Collins et al. [29], 2002 I NA NA 3780
I NA NA 2220
I NA NA 8560
I NA NA 9810
I NA NA 5376
Nathwani et al. [30], 1991 T 24 M Papua New Guinea Chloroquine, pyrimethamine
Chin et al. [31], 1971 E M NA NA
E M NA NA
E M NA NA
E M NA NA
E M NA NA
Garnham et al. [32], 1955 I NA NA
I NA NA
Jeffery [33], 1954 I NA NA
I NA NA
  1. T tourist, E sporozoite induced experimental infection, I malaria infection therapy in neurosyphilis patients, M male, F female, NA not applicable, – not mentioned in the original publication